Medicare Part B Covered ($0 Copay)PANEL-OPH-20

Inherited Ophthalmic & Vision Health

Many degenerative eye diseases progress silently before irreversible optic nerve or retinal damage occurs. This panel investigates genetic variants associated with age-related macular degeneration (AMD), juvenile and open-angle glaucoma, and inherited retinal dystrophies—enabling ophthalmologists to implement early vision-saving interventions and targeted antioxidant therapies.

Ophthalmic Genes20 Targets

Out-of-Pocket$0.00 (Part B)

CollectionCheek Swab

Lab CertifiedCLIA & CAP

Check If You Qualify

Takes under 2 minutes • 100% Covered under Medicare Part B

Verify $0 Eligibility →

HIPAA 256-Bit Encrypted

Who Should Consider This Screening?

Healthcare providers recommend this diagnostic panel for individuals with the following personal or family health indicators:

Early onset of macular degeneration symptoms before age 60.

Immediate family member diagnosed with glaucoma at a young age (<50 years).

Unexplained progressive loss of night vision or peripheral visual fields.

Family history of inherited retinal dystrophy or Stargardt disease.

Biomarkers & Genes Evaluated in this Panel

Processed using high-complexity Next-Generation Sequencing (NGS) in CLIA-certified and CAP-accredited partner laboratories.

Gene Symbol / Name	Clinical Significance	Actionable Impact
ABCA4 & BEST1Retinal ATP-Binding Cassette Transporters	Primary loci for Stargardt disease, vitelliform macular dystrophy, and inherited maculopathies.	Directs strict blue-light/UV protection, AREDS2 nutritional adjustments, and micro-perimetry tracking.
MYOC & OPTNMyocilin & Optineurin Trabecular Regulators	Associated with early-onset primary open-angle glaucoma and normal-tension glaucoma.	Guides proactive intraocular pressure (IOP) reduction protocols before visual field constriction occurs.
RPGR & RHORetinitis Pigmentosa GTPase & Rhodopsin Photoreceptors	Critical for rod and cone photoreceptor maintenance and dark adaptation.	Qualifies eligible patients for emerging gene therapy protocols and specialized low-vision rehabilitation.

Sample Report & Diagnostic Action Plan

Every patient receives an easy-to-understand diagnostic summary and a detailed clinical report tailored for their primary care doctor.

Sample Result ClassificationModerate Risk Factor

Identified Finding:

High-risk susceptibility alleles detected in complement factor H (CFH) and ARMS2 macular risk loci.

Clinician Recommendation:

Recommend semi-annual dilated retinal exams, Amsler grid self-monitoring, and initiating AREDS 2 formula antioxidant supplementation.

Medicare Part B Coverage Guidelines

Understand how federal CMS medical necessity guidelines apply to this specific diagnostic screening:

Covered 100% When Medically Necessary

Medicare Part B covers ophthalmic genetic diagnostics when ordered by an attending physician or ophthalmologist for progressive visual impairment or inherited retinal dystrophies.

Our network of state-licensed physicians reviews your medical profile to confirm eligibility before any kit is mailed.

$0 Out-of-Pocket for Qualifying Seniors

Ready to Check Your Eligibility for Inherited Ophthalmic & Vision Health?

Takes under 2 minutes • Painless at-home cheek swab • 100% Physician Reviewed

Start 2-Minute Pre-Qualification →